Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVeradermics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.65 | -$0.65 | -$0.65 |
| Q2 2026 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q3 2026 | 1 | -$0.61 | -$0.61 | -$0.61 |
| Q4 2026 | 1 | -$0.67 | -$0.67 | -$0.67 |
| Q1 2027 | 1 | -$0.63 | -$0.63 | -$0.63 |
| Q2 2027 | 1 | -$0.70 | -$0.70 | -$0.70 |
| Q3 2027 | 1 | -$0.77 | -$0.77 | -$0.77 |
| Q4 2027 | 1 | -$1.02 | -$1.02 | -$1.02 |
Veradermics Inc Earnings Date And Information
Veradermics Inc last posted its earnings results on Monday, March 30th, 2026. The company reported $-1.06053 earnings per share for the quarter, topping analysts' consensus estimates of $-1.81184 by $0.75131. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Veradermics Inc has generated $0 earnings per share over the last year ($-0.14 diluted earnings per share) and currently has a price-to-earnings ratio of -840.44. Veradermics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Veradermics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 2024 | N/A | -$0.03 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Veradermics Inc Earnings: FAQ's
In the previous quarter, Veradermics Inc (:MANE) reported $-1.06053 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.81184 by $0.75131.
The conference call for Veradermics Inc's latest earnings report can be listened to online.
The conference call transcript for Veradermics Inc's latest earnings report can be read online.
Veradermics Inc (:MANE) has a recorded net income of $-26,488,000.Veradermics Inc has generated $-0.14 earnings per share over the last four quarters.
Veradermics Inc (:MANE) has a price-to-earnings ratio of -840.44 and price/earnings-to-growth ratio is -8.4.